Peroxide-induced membrane blebbing in endothelial cells associated with glutathione oxidation but not apoptosis

Roosje M. A. van Gorp1, Jos L. V. Broers2, Chris P. M. Reutelingsperger3, Nancy M. H. J. Bronnenberg1, Gerard Hornstra1, Maria C. E. van Dam-Mieras3, and Johan W. M. Heemskerk1,3

Departments of 1 Human Biology, 2 Molecular Cell Biology and Genetics, and 3 Biochemistry, Maastricht University, 6200 MD Maastricht, The Netherlands


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cells under oxidative stress induced by peroxides undergo functional and morphological changes, which often resemble those observed during apoptosis. Peroxides, however, also cause the oxidation of intracellular reduced glutathione (GSH). We investigated the relation between these peroxide-induced effects by using human umbilical vein endothelial cells (HUVEC) and two HUVEC-derived cell lines, ECRF24 and ECV304. With HUVEC, tert-butyl hydroperoxide (tBH) or hydrogen peroxide application in the presence of serum induced, in a dose-dependent way, reorganization of the actin cytoskeleton, membrane blebbing, and nuclear condensation. These processes were accompanied by transient oxidation of GSH. With ECRF24 cells, this treatment resulted in less blebbing and a shorter period of GSH oxidation. However, repeated tBH addition increased the number of blebbing cells and prolonged the period of GSH oxidation. ECV304 cells were even more resistant to peroxide-induced bleb formation and GSH oxidation. Inhibition of glutathione reductase activity potentiated the peroxide-induced blebbing response in HUVEC and ECRF24 cells, but not in ECV304 cells. Neither membrane blebbing nor nuclear condensation in any of these cell types was due to apoptosis, as evidenced by the absence of surface expression of phosphatidylserine or fragmentation of DNA, even after prolonged incubations with tBH, although high tBH concentrations lead to nonapoptotic death. We conclude that, in endothelial cells, peroxide-induced cytoskeletal reorganization and bleb formation correlate with the degree of GSH oxidation but do not represent an early stage of the apoptotic process.

apoptosis; endothelial cells; glutathione; membrane blebbing


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

BECAUSE OF THEIR LOCATION at the interface of the vascular system, endothelial cells in the blood vessel wall are from time to time exposed to peroxides, for instance, during local inflammatory reactions or contact with oxidized lipoproteins. In vitro experiments have indicated that endothelial and other cells, when subjected to oxidative stress with hydrogen peroxide or tert-butyl hydroperoxide (tBH), undergo remarkable changes in morphology and in the structure of the actin cytoskeleton, often resulting in membrane blebbing in a manner resembling that due to apoptosis (programmed cell death) (4, 14, 15, 19, 28). A whole variety of intracellular signals have been put forward as intermediates of these peroxide-evoked changes in cell function and structure, e.g., elevated levels of intracellular Ca2+ (9, 38); activation of phospholipase D (30), mitogen-activated protein kinases (5, 20), or calpain (28); heat shock protein 27 phosphorylation (12, 19); and changed concentrations of cGMP (23) or cAMP (16). However, the precise mechanism by which peroxides, and thus oxidative stress, trigger cells is still a matter of debate.

Another well-documented direct effect of peroxides, and especially of tBH, on cells is the oxidation of cytosolic glutathione, which is normally present in its reduced form (GSH) (8, 33). Although there are good indications of ties between oxidative stress, glutathione depletion, and the onset of apoptosis (reviewed in Ref. 6), these have not yet been studied in endothelial cells. In the present paper, we report on the effects of tBH on a number of structural and functional properties of human umbilical vein endothelial cells (HUVEC) and two HUVEC-derived cell lines, ECV304 (34) and ECRF24 (10). We note remarkable differences in the capacities of these cells to respond by actin reorganization, membrane blebbing, and nuclear condensation, which closely parallel differences in sensitivity to GSH oxidation. Because these tBH-evoked morphological changes suggested the commencement of apoptosis, we determined two markers of this process, phosphatidylserine (PS) externalization (21, 35) and DNA fragmentation (31). It appeared that even prolonged incubation with high doses of tBH failed to induce these apoptotic responses.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Materials. Cell culture media were purchased from Life Technologies (Breda, The Netherlands), human serum was provided by the Red Cross Blood Bank Zuid-Limburg (Maastricht, The Netherlands), bovine brain extract was from Boehringer (Mannheim, Germany), heparin was from ICN (Zoetermeer, The Netherlands), and FCS was from Integro (Zaandam, The Netherlands). Oregon green 488-labeled annexin V (Apoptest) was supplied by Nexins Research (Hoeven, The Netherlands), and rhodamine-labeled phalloidin was supplied by Molecular Probes (Leiden, The Netherlands). tBH was obtained from Aldrich (Milwaukee, WI). Other reagents, including 4',6-diamidino-2-phenylindole (DAPI) and L-buthionine-[S,R]-sulfoximine (BSO), were purchased from Sigma (St. Louis, MO); 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) was a gift from Bristol-Myers Squibb (Evansville, IN).

Cell culturing. HUVEC were collected by trypsin digestion and cultured on gelatin-coated culture dishes in 1 vol medium 199 and 1 vol RPMI 1640, supplemented with 20% (vol/vol) human serum, bovine brain extract (5 µg/ml), and heparin (10 U/ml), as described previously (39). Repetitions of experiments were always performed with HUVEC derived from different umbilical cords (passage 4). ECRF24 cells, kindly provided by Dr. H. Pannekoek (Dept. of Biochemistry, Academic Medical Centre, Amsterdam, The Netherlands), were grown in HUVEC culture medium, but without bovine brain extract or heparin. ECV304 cells were obtained from the European Collection of Animal Cell Cultures (Salisbury, UK) and cultured in medium 199 plus 10% (vol/vol) FCS. All experiments were performed with endothelial cells in confluent monolayers.

Microscopic inspection and staining of tBH-treated cells. Confluent monolayers of endothelial cells grown in 12-well plates were treated with 0.1-1 mM tBH in serum-containing culture medium. Cells were monitored for membrane blebbing every 10 min by phase-contrast microscopy. All experiments were run in triplicate with cells in three different wells. Usually, three independent experiments were performed in which, for HUVEC, a different isolation was used for each experiment. The observer was blind to the experimental condition. For F-actin and nuclear staining, cells grown on gelatin-coated glass coverslips were washed with HEPES buffer (pH 7.45), fixed with 1% (wt/vol) paraformaldehyde for 10 min, washed with PBS, permeabilized with 0.02% (wt/vol) saponin, and finally stained with rhodamine-labeled phalloidin (2.5 U/ml) for 45 min in the dark. DAPI (62.5 µg/ml) was used for nuclear counterstaining. For quantification of actin rearrangements and nuclear condensation, two to three independent experiments were performed and for each experiment at least three microscopic fields were inspected. Confocal laser scanning microscopy was performed with a Bio-Rad MRC 600 system as described elsewhere (24).

Markers of apoptosis and necrosis. Endothelial cells were treated with tBH or staurosporine in serum-containing medium for 1 or 16 h in 12-well plates, after which the medium (possibly containing floating cells) was removed and stored. Cells were trypsinized, and then the corresponding medium was added again. Cells pelleted by centrifugation were resuspended in 500 µl HEPES buffer, pH 7.45, containing (in mM) 150 NaCl, 10 HEPES, 5 KCl, 1.8 CaCl2, 1 MgCl2,10 D-glucose, and L-glutamic acid and 0.25% (wt/vol) BSA. The surface expression of negatively charged PS in these unfixed cells was determined by flow cytometry, by using as a probe Oregon green 488-labeled annexin V (0.25 µg/ml) (17, 21). The membrane-impermeable DNA stain propidium iodide (1 µg/ml) was included in these experiments to determine membrane integrity as a marker of cell vitality. Cells with a low level of propidium iodide staining were defined to be vital; cells with a high level of annexin V binding together with a low level of propidium iodide staining were defined as apoptotic. Finally, all cells with a high level of propidium iodide staining were defined as necrotic (36).

The fragmentation of DNA was measured as DNA hypodiploidy in permeabilized, fixed cells. After being harvested by trypsinization, cells in suspension were fixed with 1% (wt/vol) paraformaldehyde for 10 min and then permeabilized with 0.02% (wt/vol) saponin for 5 min. These cells were analyzed after the addition of propidium iodide (1 µg/ml), also with a flow cytometer (31).

Determination of GSH and total glutathione levels. After incubation of the endothelial cells on six-well culture plates, cellular proteins were precipitated by adding directly to the monolayer 500 µl of an ice-cold solution of 4% (wt/vol) TCA and 2 mM EDTA. The culture plates were then incubated at 4°C for 15 min, after which cell lysates were collected and centrifuged at 9,000 g for 5 min (4°C). The resulting supernatants were used for the measurement of GSH and total glutathione levels, as previously described (37). Glutathione levels are expressed as percentages of the levels from control incubations. Unstimulated HUVEC and ECRF24 and ECV304 cells each contained ~120 nmol total glutathione/mg cellular protein.

Inhibition of glutathione reductase levels. Confluent monolayers of endothelial cells were incubated with specific glutathione reductase inhibitor BCNU (50 µM) (37) in culture medium. After 30 min the BCNU-containing medium was replaced by fresh culture medium and the cells were allowed to recover for 2 h, essentially as described previously (5). The BCNU-treated cells were then used for other experimentation.

Determination of NADPH in endothelial cell monolayers. Endothelial cells were cultured on gelatin-coated glass coverslips in 12-well culture plates. The coverslips were mounted in an open chamber that was placed on the stage of a Diaphot inverted fluorescence microscope (Nikon, Tokyo, Japan). Changes in autofluorescence, reflecting intracellular levels of NADPH (22a), in individual cells at 37°C were measured with a Quanticell fluorometric system (Applied Imaging, Sunderland, UK), basically following previously described procedures (17). Excitation and emission wavelengths were 340 and 510 nm, respectively.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Changes in actin cytoskeleton and cell morphology. The effects of tBH on confluent monolayers of endothelial cells in the continuous presence of serum-containing culture medium were investigated. HUVEC were treated with a low dose of 0.1 mM tBH, and a microscopic inspection showed that this resulted, within 30 min, in the development of plasma membrane blebs in, on average, 26% of the cells, although there was considerable variation between cells derived from different umbilical veins. After the cells were stained for F-actin to visualize peroxide-induced changes in the actin cytoskeleton, it appeared that, in the bleb-forming cells, the normal filamentous pattern of F-actin had been completely changed into a pattern with F-actin redistributed as a diffuse ring along the cellular border and blebs (Fig. 1). The interior of the cell body and the membrane blebs were practically devoid of F-actin. Counterstaining with DAPI indicated that most of the blebbing cells also had a condensed nucleus (Fig. 2). Quantitative analysis revealed that the number of cells with nuclear condensation was indeed similar to the number of bleb-forming cells (Table 1). When a higher dose of 0.4 mM tBH was used, a larger fraction of cells showed these morphological changes. The same effects on cellular structure were observed when HUVEC were incubated with hydrogen peroxide instead of tBH. For instance, 0.5 mM hydrogen peroxide induced membrane blebbing in 14.7 ± 4.6% of total cells (mean ± SE; n = 5). To study the dose dependency of this process, HUVEC were exposed to various concentrations of tBH in culture medium and visually checked for the appearance of membrane blebs. As shown in Fig. 3, the blebbing response was found to increase in the range of 0.1-1.5 mM tBH, with almost all cells showing blebs at the highest concentration. Typically, the number of peroxide-induced blebbing cells decreased considerably after longer incubation times with lower peroxide concentrations, and the majority of them regained normal morphology. For hydrogen peroxide stimulation (0.5 mM), 94.6 ± 3.8% (n = 4) of the blebs had disappeared after 2 h of incubation, whereas with tBH (0.1 mM) an incubation time of 4-8 h was needed to achieve this level of reduction. These results strongly suggest that the bleb-forming process is reversible.


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 1.   Confocal laser scanning micrograph of stained F-actin in human umbilical vein endothelial cell (HUVEC) treated with tert-butyl hydroperoxide (tBH). HUVEC grown to confluence were incubated with 0.1 mM tBH at 37°C. After 60 min of treatment, cells were fixed and stained for F-actin with rhodamine-labeled phalloidin. A representative image of a blebbing cell is shown. Note that blebbing cell has rounded up to a higher plateau and is observed on top of surrounding cells. Bar, 8 µm.



View larger version (74K):
[in this window]
[in a new window]
 
Fig. 2.   Nuclear condensation in blebbing endothelial cells. Photographs are from 1 microscopic field observed for F-actin (A) or DNA (B) staining. HUVEC grown to confluence were incubated with 0.1 mM tBH for 60 min, fixed, and stained for F-actin with rhodamine-labeled phalloidin and then counterstained for DNA with 4',6-diamidino-2-phenylindole (DAPI). Note condensed DNA of blebbing cell. Bars, 11 µm.


                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Effects of tBH on membrane blebbing and nuclear condensation in endothelial cells



View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3.   Dose dependency of tBH-induced membrane blebbing in HUVEC. Confluent monolayers of HUVEC were incubated with 0.1-1.5 mM tBH in culture medium (37°C). Cells were inspected by microscopy for membrane blebbing for 10-60 min to determine maximal no. of bleb-forming cells. Data are means ± SE, n = 3.

The application of 0.1 mM tBH to ECRF24 cells had little effect on the cytoskeletal structure. However, when these cells were subjected to five consecutive treatments with 0.1 mM tBH at 10-min intervals, significant bleb formation was observed, again with F-actin aligning along the blebbing structures (Fig. 4). Under these conditions, ~10% of the cells showed blebbing and nuclear condensation (Table 1). In contrast, ECV304 cells were unable to respond by bleb formation or nuclear condensation, not even after five consecutive incubations with a high concentration of 1 mM tBH (Table 1). Similarly, hydrogen peroxide (1 mM) did not evoke these morphological responses in ECV304 cells (not shown). Together, these data indicate that HUVEC more strongly than ECRF24 cells respond to peroxides by changes of cell actin skeleton and structure, whereas ECV304 cells are remarkably resistant in this respect.


View larger version (140K):
[in this window]
[in a new window]
 
Fig. 4.   Confocal laser scanning micrograph of stained F-actin in ECRF24 cells treated with tBH. Confluent ECRF24 cells were incubated 5 times with 0.1 mM tBH, with 10-min intervals between each incubation. After 60 min of treatment, cells were fixed and stained for F-actin with rhodamine-labeled phalloidin. Representative image of a blebbing cell is shown. Bar, 5 µm.

Bleb formation in the absence of apoptosis. The appearance of circular F-actin, membrane blebbing, and nuclear condensation in the peroxide-treated HUVEC and ECRF24 cells closely resembles the alterations in cell morphology in an early stage of apoptosis (26, 27, 40). We therefore investigated whether tBH was capable of initiating this process in these endothelial cells by measuring two characteristic apoptotic responses: appearance of PS at the plasma membrane outer surface as an early marker (21, 35) and fragmentation of DNA to mark more-advanced stages (31). For comparison, the cells were triggered with the protein kinase inhibitor staurosporine, which is a well-known inducer of apoptosis in endothelial cells (3).

The analysis of these responses was performed by harvesting the activated cells from the monolayer by trypsinization and subjecting them to flow cytometry. The externalization of PS was routinely determined by analyzing the capability of unfixed cells to bind the PS-specific probe Oregon green 488-labeled annexin V (36). On the other hand, DNA ploidy in fixed, permeabilized cells was separately measured with the DNA probe propidium iodide (31). After 60 min of exposure of HUVEC (one treatment) or ECRF24 cells (five treatments) to 0.1 mM tBH, essentially no externalization of PS or fragmentation of DNA was observed (Fig. 5, A-D). Nevertheless, microscopic inspection had shown that many of the cells in the monolayer responded by membrane blebbing. A 60-min incubation with staurosporine (4 µM) resulted in PS externalization in some of the ECRF24 cells but not in HUVEC, whereas effects on DNA ploidy were not detected (Fig. 5, E and F). Because apoptosis is a slowly developing process, the effects of these agonists were also determined after longer incubation periods. However, even after 16 h of treatment with this concentration of tBH, neither in HUVEC nor in ECRF24 cells was significant PS externalization or DNA hypodiploidy observed (Fig. 6, A-D). As expected, a 16-h incubation with staurosporine led to massive PS exposure and DNA fragmentation in both HUVEC and ECRF24 cells (Fig. 6, E and F).


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 5.   Short-term effects of tBH on phosphatidylserine (PS) exposure and DNA fragmentation in endothelial cells. Confluent monolayers of HUVEC (left) or ECRF24 cells (right) remained untreated (A, B) or were incubated with tBH (0.1 mM; 1 treatment for HUVEC and 5 treatments for ECRF24 cells) (C, D) or 4 µM staurosporine (E, F). After 60 min of incubation, cells were harvested and were either stained with Oregon green (OG) 488-labeled annexin V or, alternatively, fixed and stained with propidium iodide. Fluorescence of collected cells was analyzed with a flow cytometer. Lower channel nos. represent autofluorescence of unlabeled cells (dotted lines); nos. in italics are percentages of annexin V-positive cells. Results are from typical experiment representative of 4-6 others.



View larger version (36K):
[in this window]
[in a new window]
 
Fig. 6.   Long-term effects of tBH on PS exposure and DNA fragmentation in endothelial cells. HUVEC (left) or ECRF24 cells (right) remained untreated (A, B) or were treated with tBH (C, D) or staurosporine (E, F) during a period of 16 h. Further conditions and analysis are as described for Fig. 5. Numbers in italics are percentages of annexin V-positive cells. Results are representative of those from 4-6 experiments.

To confirm the suggestion that tBH did not evoke apoptosis under the conditions employed, HUVEC and ECRF24 cells were subsequently treated with various tBH concentrations and quantitatively analyzed for fractions of vital, apoptotic, and necrotic cells, again by flow cytometry. These experiments were carried out with unfixed cells that were double-stained with Oregon green 488-labeled annexin V (to detect PS-exposing apoptotic and necrotic cells) and propidium iodide (to detect necrotic cells with increased membrane permeability). As shown in Table 2, in either cell type, small fractions of apoptotic and necrotic cells were detected in the absence of stimulation. Such low fractions of "spontaneously" apoptotic cells have also been observed by others and are in part due to the cell harvesting procedure applied (36). Short or prolonged treatment with 0.1 mM tBH did not influence the apoptotic or necrotic cell fractions. However, treatment with a higher peroxide dose of 0.4 mM, sufficient to cause blebbing in ~50% of HUVEC, resulted in considerable loss in cell vitality (necrosis) but no more than marginally increased the fraction of apoptotic cells (Table 2). From these results, it was concluded that the tBH-induced formation of blebs is not an initial sign of apoptosis.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Effect of tBH on endothelial viability

Effects on glutathione oxidation. To determine how the cell line-dependent variation in membrane blebbing was related to the redox or sulfhydryl state of the cells, we compared the effects of tBH on the intracellular glutathione levels in HUVEC and ECRF24 and ECV304 cells. For HUVEC, a single incubation with 0.1 mM tBH immediately decreased the level of GSH to ~30% of the resting value, after which it was slowly restored. After 60 min, a considerable part of the oxidized glutathione still had not been regenerated as GSH (Table 3). Higher tBH concentrations resulted in more severe GSH oxidation (data not shown). When ECRF24 cells were used, treatment with 0.1 mM tBH also resulted in a pronounced decrease in GSH level but the decrease was followed by a more rapid recovery, so that all glutathione had regained the reduced form within 60 min (Table 3). The repeated addition of 0.1 mM tBH to ECRF24 cells considerably delayed this recovery process. At 60 min after five consecutive tBH incubations, the GSH level still reached only 52.9 ± 11.8% (mean ± SE; n = 4) of the total glutathione concentration. These data suggest that HUVEC differ from ECRF24 cells, not so much in their GSH peroxidase reactivities (i.e., the enzymatic reaction inactivating peroxides at the expense of GSH) but more in their glutathione reductase capacities (by which oxidized glutathione is reformed to GSH). It should be noted that, in both HUVEC and ECRF24 cells, the total glutathione concentration decreased gradually during the incubation period (Table 3), possibly because of the efflux of oxidized glutathione out of the cells, as has been reported for hepatocytes (8).

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Glutathione-oxidizing effect of tBH on endothelial cells

In marked contrast to the two other cell types, incubation of ECV304 cells with 0.1 (not shown) or 1 mM tBH (Table 3) was without significant effect on the total glutathione or GSH concentration. Even after five additions of 1 mM tBH, the GSH level was still 98.2 ± 4.9% of the total glutathione level (mean ± SE; n = 6). Treatment of ECV304 cells with the glutathione synthesis inhibitor BSO (25 µM for 20 h) resulted in the expected depletion of the total glutathione concentration to 21.4 ± 2.4% (n = 4) of the control value. Triggering the BSO-treated cells with 1 mM tBH decreased the GSH level insignificantly from 21.4% to 17.8 ± 4.9%. Thus ECV304 cells appear to be remarkably resistant to GSH oxidation by peroxides. This was confirmed by performing incubations with various concentrations of hydrogen peroxide. For instance, 0.5 mM hydrogen peroxide led to a level of GSH oxidation similar to that produced by 0.1 mM tBH in HUVEC but did not change the GSH level in ECV304 cells.

When we compare the data for the various endothelial cell lines, we note a marked parallel in the effects of tBH and hydrogen peroxide on cytoskeleton-dependent changes in morphology (bleb formation and nuclear condensation) and in their effects on the magnitude and duration of GSH oxidation. Responsiveness to the peroxides was always in the order HUVEC > ECRF24 cells > ECV304 cells. Further experimentation was designed to better define the relationship between the GSH-oxidizing and morphological effects of the peroxides.

Relation between glutathione oxidation and bleb formation. To further investigate the role of GSH oxidation in tBH-induced membrane blebbing, cells were pretreated with the specific glutathione reductase inhibitor BCNU (8, 37). When applied to monolayers of HUVEC or the cell lines, this treatment was without effect on the total glutathione concentration. For HUVEC and ECRF24 cells, the subsequent addition of tBH caused a considerable reduction in the GSH redox state, as expected. At the same time, the BCNU treatment more than doubled the peroxide-induced blebbing response (Table 4). However, in ECV304 cells treated with BCNU, tBH still did not lead to notable GSH oxidation and membrane blebbing remained absent. Significant GSH oxidation and bleb formation were also not detected in ECV304 cells that were pretreated with the glutathione synthesis inhibitor BSO, although the level of total glutathione was considerably reduced in the cells (see above). In another series of experiments, HUVEC and other cells were treated with the membrane-permeable sulfhydryl agent N-ethylmaleimide (30 µM), an agent that oxidizes GSH and protein thiols in endothelial cells (29). When applied to HUVEC, this treatment resulted in massive F-actin rearrangement and in membrane blebbing in 10.0 ± 1.0% of the cells (mean ± SE; n = 3). Similar blebbing morphology was observed when these cells were incubated with another sulfhydryl reagent, diamide.

                              
View this table:
[in this window]
[in a new window]
 
Table 4.   Effects of BCNU on tBH-induced glutathione oxidation and membrane blebbing in endothelial cells

To explain why only part of the tBH-treated cells in a monolayer exhibit membrane blebbing under conditions of GSH oxidation, the effect of peroxide on the autofluorescence of endothelial cells in the monolayer was measured, the level of which largely reflects the intracellular NADPH concentration (22a). The oxidation of NADPH is indeed considered to be an adequate measure of the cellular redox state (8, 33). Monitoring the fluorescence microscopic images from a monolayer of HUVEC that were exposed to 0.1 mM tBH revealed considerable cell-to-cell variety in the peroxide-evoked decrease in autofluorescence. Within a period of 15 min, the fluorescence of some, but not of all, cells started to return to the original level (Fig. 7). These data thus point to a significant intercellular variation in the degree and duration of NADPH (and thus GSH) oxidation. Taken together, these results suggest that a change in the redox state and/or the oxidation or thiolation of GSH is important for the bleb-forming process, not the absolute level of GSH.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 7.   NADPH-oxidizing effect of tBH on endothelial cells in monolayer. HUVEC on glass coverslips were incubated with 0.1 mM tBH at 37°C. NADPH autofluorescence was determined by fluorescence microscopic imaging at excitation and emission wavelengths of 340 and 510 nm, respectively. Shown are traces of autofluorescence of 2 individual cells within 1 microscopic field. Later visual inspection showed blebbing in ~15% of cells in this particular experiment. Data are representative of those from 4 independent measurements.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In this paper, we contrast the responses of HUVEC and two HUVEC-derived cell lines (ECRF24 and ECV304) to the glutathione-oxidizing compounds tBH and hydrogen peroxide with regard to membrane blebbing, actin cytoskeleton rearrangement, nuclear condensation, and GSH oxidation. For HUVEC, the peroxides increased in a dose-dependent way the number of cells undergoing bleb formation and the other morphological changes. As far as we could detect, many or all of the blebbing cells contained an actin cytoskeleton located on the surface and also a condensed nucleus (Table 1, Fig. 2). The time scale of these changes was quite similar to that of the transient, peroxide-induced oxidation of GSH (Table 3). Compared with HUVEC, the cell lines, ECV304 more so than ECRF24, were more resistant to both the morphological changes and GSH oxidation. Further confirmation of this relation between peroxide-induced glutathione-oxidizing capacity and membrane blebbing could be obtained by treating the cells with the glutathione reductase inhibitor BCNU, which increased the bleb formation and the degree of GSH oxidation in HUVEC and ECRF24 cells but was unable to induce either response in ECV304 cells (Table 4).

Although the oxidative stress imposed by tBH and hydrogen peroxide may evoke apoptosis in various cells (4, 14, 32), the morphological changes observed in the present study are unlikely to result from an apoptotic process, because they were not accompanied by early markers of apoptosis such as surface expression of PS or fragmentation of DNA. This holds for HUVEC as well as for ECRF24 cells (Figs. 5 and 6). More precisely, at lower peroxide concentrations, the number of blebbing cells was found to decrease in time (suggesting reversibility of the process), without indications of apoptosis (Table 2). On the other hand, at higher peroxide doses, at which many of the cells showed blebs, a considerable fraction of the cells became necrotic but not apoptotic. Apparently, depending on the peroxide concentration, blebbing endothelial cells either recover or die a nonapoptotic death. We therefore conclude that, under the present experimental conditions, 1) the peroxide-induced morphological changes correlate with the degree of GSH oxidation but are not early indications of apoptosis and 2) HUVEC and the HUVEC-derived cell lines are fairly resistant to apoptosis.

There is only limited literature directly comparing the properties of ECRF24 and ECV304 cells with those of the parental cells. ECRF24 was produced by transfection of HUVEC with the E6/E7 open reading frame of human papilloma virus 16 (10), whereas ECV304 is the result of a spontaneous HUVEC transformation (34). The ECRF24 line closely resembles HUVEC with respect to cell morphology, growth characteristics, and expression of von Willebrand factor and selective surface adhesion molecules (10). Similarly, the ECV304 line possesses many HUVEC-like characteristics in terms of morphology and signal transduction mechanisms, although a certain degree of dedifferentiation may have occurred (1, 11, 18). From the present results, it is likely that these cell lines differ from HUVEC in their capabilities to detoxify peroxides by using the redox equivalents from intracellular GSH. We hypothesize that this difference is responsible for the decreased blebbing response. However, the possibility that the cell lines lack one or more of the other intracellular signaling modules that are unrelated to glutathione metabolism and that participate in peroxide-induced cytoskeleton rearrangement and the blebbing response cannot be excluded. Indeed, a wide variety of peroxide-induced signaling pathways that may or may not be influenced by the glutathione state of the cells have been described (see INTRODUCTION). It is thus still possible that the processes of bleb formation and GSH oxidation are epiphenomena without a causal relationship. This might also explain why not all cells start to bleb in response to low peroxide concentrations, whereas most (or all) of them will undergo a change in their GSH levels. However, it is also possible that both the degree and time period of GSH oxidation may determine the blebbing phenomenon. In agreement with this is the observation that within a single endothelial monolayer, considerable cell-to-cell heterogeneity in the degree of peroxide-induced NADPH oxidation was observed (Fig. 7). Because the peroxide-induced oxidation of GSH and NADPH points to a changed intracellular redox state, it might well be that such an altered state, rather than a direct effect of oxidized GSH, is affecting the cell morphology.

The present results differ from those of others, who report that mild oxidative stress such as that evoked by peroxide triggers the apoptotic process in endothelial cells (7, 22, 32). It should be noted that our experiments were performed with cells that were treated with tBH or hydrogen peroxide in the continuous presence of serum with growth factors; most of the other reported studies have been performed with cells activated in serum (albumin)-free media. There are good indications that serum deprivation induces apoptosis in endothelial cells (41), whereas growth factor supplementation protects the cells from entering this process (13). At the molecular level, it has been proposed that the antiapoptotic effect of serum (albumin) and growth factors results from a cross talk between stress-stimulated protein kinase pathways (proapoptotic) and parallel growth factor-activated survival pathways (antiapoptotic) (2, 20). In this model, the final effect of stress activators such as peroxide would be influenced by the activity of the survival pathways. Thus peroxide application to endothelial cells that are maintained on serum might cause a mild stress response such as membrane blebbing (possibly by a changed GSH oxidation state) without trapping the cells into an apoptotic program.

Although the endothelial cells in the inner walls of blood vessels can easily become exposed to peroxides under stress conditions, such as those produced by activated neutrophils (25), the present data suggest that apoptosis is not a likely result under such in vivo conditions. On the other hand, the peroxide-evoked bleb formation may seriously impede the interface function of endothelial cells in the vessel wall, because it is necessarily accompanied by cell retraction and thus by the increased permeability of the endothelium.


    ACKNOWLEDGEMENTS

We thank Dr. H. Pannekoek for a gift of the endothelial cell line ECRF24 and Dr. W. M. J. Vuist for stimulating discussions.


    FOOTNOTES

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: R. M. A. van Gorp, Dept. of Human Biology, Maastricht Univ., PO Box 616, 6200 MD Maastricht, The Netherlands (E-mail: R.vanGorp{at}hb.unimaas.nl).

Received 14 July 1998; accepted in final form 19 March 1999.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Abedi, H., and I. Zachary. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem. 272: 15442-15451, 1997[Abstract/Free Full Text].

2.   Berra, E., M. T. Diaz-Meco, and J. Moscat. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phophoinositide 3-kinase/Akt pathway. J. Biol. Chem. 273: 10792-10797, 1998[Abstract/Free Full Text].

3.   Bombeli, T., A. Krasan, J. F. Tait, and J. M. Harlan. Apoptotic vascular endothelial cells become procoagulant. Blood 89: 2429-2442, 1997[Abstract/Free Full Text].

4.   Burdon, R. H., V. Gill, and D. Alliangana. Hydrogen peroxide in relation to proliferation and apoptosis in BHK-1 hamster fibroblasts. Free Radic. Res. 2: 81-93, 1996.

5.   Cantoni, O., D. Boscoboinik, M. Fiorani, B. Stäuble, and A. Azzi. The phosphorylation state of MAP-kinases modulates the cytotoxic response of smooth muscle cells to hydrogen peroxide. FEBS Lett. 389: 285-288, 1996[Medline].

6.   Cotgreave, I. A., and R. G. Gerdes. Recent trends in glutathione biochemistry---glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation? Biochem. Biophys. Res. Commun. 242: 1-9, 1998[Medline].

7.   De Bono, D. P., and W. D. Yang. Exposure to low concentrations of hydrogen peroxide causes delayed endothelial cell death and inhibits proliferation of surviving cells. Atherosclerosis 114: 235-245, 1995[Medline].

8.   Eklöw, L., P. Moldéus, and S. Orrenius. Oxidation of glutathione during hydroperoxide metabolism. A study using isolated hepatocytes and the glutathione reductase inhibitor 1,3-bis(2-chloroethyl)-1-nitrosourea. Eur. J. Biochem. 138: 459-463, 1984[Abstract].

9.   Elliott, S. J., and W. P. Schilling. Oxidative stress inhibits bradykinin-stimulated 45Ca2+ flux in pulmonary vascular endothelial cells. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H549-H556, 1991[Abstract/Free Full Text].

10.   Fontijn, R., C. Hop, H. J. Brinkman, R. Slater, A. Westerveld, J. A. van Mourik, and H. Pannekoek. Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA. Exp. Cell Res. 216: 199-207, 1995[Medline].

11.   Fuentes, E., A. Nadal, R. Jacob, and P. McNaughton. Actions of serum and plasma albumin on intracellular Ca2+ in human endothelial cells. J. Physiol. (Lond.) 540: 315-326, 1997.

12.   Guay, J., H. Lambert, G. Gingras-Breton, J. N. Lavoie, J. Huot, and J. Landry. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J. Cell Sci. 110: 357-368, 1997[Abstract/Free Full Text].

13.   Haimovitz-Friedman, A., N. Balaban, M. McLoughlin, D. Ehleiter, J. Michaeli, I. Vlodavsky, and Z. Fuks. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res. 54: 2591-2597, 1994[Abstract].

14.   Hampton, M. B., and S. Orrenius. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett. 414: 552-556, 1997[Medline].

15.   Hastie, L. E., W. F. Patton, H. B. Hechtman, and D. Sherpo. Filamin redistribution in an endothelial cell reoxygenation injury model. Free Radic. Biol. Med. 22: 955-966, 1997[Medline].

16.   Hastie, L. E., W. F. Patton, H. B. Hechtman, and D. Sherpo. H2O2-induced filamin redistribution in endothelial cells is modulated by the cyclic AMP-dependent protein kinase pathway J. Cell. Physiol. 172: 373-381, 1997[Medline].

17.   Heemskerk, J. W. M., W. M. J. Vuist, M. A. H. Feijge, C. P. M. Reutelingsperger, and T. Lindhout. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses. Blood 90: 2615-2625, 1997[Abstract/Free Full Text].

18.   Hughes, S. E. Functional characterization of the spontaneously transformed human umbilical vein endothelial cell line ECV304: use in an in vitro model of angiogenesis. Exp. Cell Res. 225: 171-185, 1996[Medline].

19.   Huot, J., F. Houle, F. Marceau, and J. Landry. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ. Res. 80: 383-392, 1997[Abstract/Free Full Text].

20.   Huot, J., F. Houle, S. Rousseau, R. G. Deschesnes, G. M. Shah, and J. Landry. SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J. Cell Biol. 143: 1361-1373, 1998[Abstract/Free Full Text].

21.   Koopman, G., C. P. M. Reutelingsperger, G. A. M. Kuijten, R. M. J. Keehnen, S. T. Pals, and M. H. J. van Oers. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415-1420, 1994[Abstract/Free Full Text].

22.   Lelli, J. L., L. L. Becks, M. I. Dabrowska, and D. B. Hinshaw. ATP converts necrosis to apoptosis in oxidant-injured endothelial cells. Free Radic. Biol. Med. 25: 694-702, 1998[Medline].

22a.   Liang, B., and H. R. Petty. Imaging neutrophil activation: analyses of the translocation and utilisation of NAD(P)H-associated autofluorescence during antibody-dependent target oxidation. J. Cell. Physiol. 152: 145-156, 1992[Medline].

23.   Liu, S. M., and T. Sundqvist. Nitric oxide and cGMP regulate endothelial permeability and F-actin distribution in hydrogen peroxide-treated endothelial cells. Exp. Cell Res. 235: 238-244, 1997[Medline].

24.   Machiels, B. M., J. L. V. Broers, Y. Raymond, L. de Ley, H. J. H. Kuijpers, N. E. H. Caberg, and F. C. S. Ramaekers. Abnormal A-type lamin organization in a human lung carcinoma cell line. Eur. J. Cell Biol. 67: 328-335, 1995[Medline].

25.   Martin, W. J., II. Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. An in vitro model of neutrophil-mediated lung injury. Am. Rev. Respir. Dis. 130: 209-213, 1984[Medline].

26.   McCarthy, N. J., M. K. B. Whyte, S. G. Gilbert, and G. I. Evan. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136: 215-227, 1997[Abstract/Free Full Text].

27.   Mills, J. C., N. L. Stone, J. Erhardt, and R. N. Pittman. Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation. J. Cell Biol. 140: 627-636, 1998[Abstract/Free Full Text].

28.   Miyoshi, H., K. Umeshita, M. Sakon, S. Imajoh-Ohmi, K. Fujitani, M. Gotoh, E. Oiki, J. Kambayashi, and M. Monden. Calpain activation in plasma membrane bleb formation during tert-butyl hydroperoxide-induced rat hepatocyte injury. Gastroenterology 110: 1897-1904, 1996[Medline].

29.   Murphy, M. E., H. M. Piper, H. Watanabe, and H. Sies. Nitric oxide production by cultured aortic endothelial cells in response to thiol depletion and replenishment. J. Biol. Chem. 266: 19378-19383, 1991[Abstract/Free Full Text].

30.   Natarajan, V., M. M. Taher, B. Roehm, N. L. Parinandi, H. H. Schmid, Z. Kiss, and J. G. Garcia. Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxides. J. Biol. Chem. 268: 930-937, 1993[Abstract/Free Full Text].

31.   Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 193: 271-279, 1991.

32.   Suhara, T., K. Fukuo, T. Sugimoto, S. Morimoto, T. Nakahashi, S. Hata, M. Shimizu, and T. Ogihara. Hydrogen peroxide induces up-regulation of FAS in human endothelial cells. J. Immunol. 160: 4042-4047, 1998[Abstract/Free Full Text].

33.   Suttorp, N., W. Toepfer, and L. Roka. Antioxidant defense mechanisms of endothelial cells: glutathione redox cycle versus catalase. Am. J. Physiol. 251 (Cell Physiol. 20): C671-C680, 1986[Abstract/Free Full Text].

34.   Takahashi, K., Y. Sawasaki, J. Hata, K. Mukai, and T. Goto. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell. Dev. Biol. 26: 265-274, 1990[Medline].

35.   Van Engeland, M., H. J. H. Kuijpers, F. C. S. Ramaekers, C. P. M. Reutelingsperger, and B. Schutte. Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp. Cell Res. 235: 421-430, 1997[Medline].

36.   Van Engeland, M., F. C. S. Ramaekers, B. Schutte, and C. P. M. Reutelingsperger. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24: 131-139, 1996[Medline].

37.   Van Gorp, R. M. A., M. C. E. van Dam-Mieras, G. Hornstra, and J. W. M. Heemskerk. Effect of membrane-permeable sulfhydryl reagents and depletion of glutathione on calcium mobilisation in human platelets. Biochem. Pharmacol. 53: 1533-1542, 1997[Medline].

38.   Vischer, U. M., L. Jornot, C. B. Wollheim, and J. Theler. Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells. Blood 85: 3164-3172, 1995[Abstract/Free Full Text].

39.   Vossen, R. C. R. M., M. C. E. van Dam-Mieras, P. J. M. R. Lemmens, G. Hornstra, and R. F. A. Zwaal. Membrane fatty acid composition and endothelial cell functional properties. Biochim. Biophys. Acta 1083: 243-251, 1991[Medline].

40.   Wyllie, A. H., J. F. R. Kerr, and A. R. Currie. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68: 251-306, 1980[Medline].

41.   Zoellner, H., M. Höfler, R. Beckmann, P. Hufnagl, E. Vanyek, E. Bielek, J. Wojta, A. Fabry, S. Lockie, and B. R. Binder. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J. Cell Sci. 109: 2571-2580, 1996[Abstract/Free Full Text].


Am J Physiol Cell Physiol 277(1):C20-C28
0002-9513/99 $5.00 Copyright © 1999 the American Physiological Society